First AD

Second AD

Breast Cancer

ELI-22-OSD1261 - /clinical/colorectal-cancer

 Breast Cancer condition center page is a comprehensive resource for clinical news and expert insights on various types of breast cancer, including those that are triple negative, hormone receptor positive, and/or HER2 positive. This page features news articles, interviews in written and video format, and podcasts that focus on treatment advances and ongoing research in breast cancer.

Emerging Treatment Modalities in Metastatic Breast Cancer: Highlights from SABCS 2022 and Beyond

Insights

Komal Jhaveri, MD, FACP, discusses the role of capivasertib in ER-positive HER2-negative mBC and the design and outcomes of the CAPItello 291 trial.

The Role of Capivasertib in ER+/HER- mBC

Overview of ER+/HER2- Metastatic Breast Cancer (mBC)

Standards of Care in the Frontline Treatment of ER+/HER2- mBC

Use of Second-Generation Oral SERDs in ER+/HER2- mBC

Standard Practices for the Management of Triple-Negative Breast Cancer (TNBC)

The Role of ADCs in the Treatment of TNBC

Investigational ADCs for Treatment of TNBC

Emerging Concepts in mBC Treatment